[Genetic polymorphism of a human gene locus containing the tumor necrosis factor gene: new markers of susceptibility to multiple sclerosis]. 1995

M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
March 2011, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
January 2007, Medicina,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
January 2015, Iranian Red Crescent medical journal,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
August 1993, Doklady Akademii nauk,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
March 1995, Human immunology,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
November 1995, Multiple sclerosis (Houndmills, Basingstoke, England),
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
March 2014, Noro psikiyatri arsivi,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
December 2002, Zhonghua nei ke za zhi,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
April 1990, Journal of neuroimmunology,
M A Sudomoina, and A N Boĭko, and R L Turetskaia, and E I Gusev, and T L Demina, and O O Favorova
March 2011, Experimental and therapeutic medicine,
Copied contents to your clipboard!